Northern Trust’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.3M Buy
1,272,611
+36,782
+3% +$879K ﹤0.01% 1464
2025
Q4
$33M Sell
1,235,829
-67,707
-5% -$1.62M ﹤0.01% 1368
2025
Q3
$27.8M Buy
1,303,536
+920
+0.1% +$21.8K ﹤0.01% 1482
2025
Q2
$28.1M Sell
1,302,616
-72,597
-5% -$1.35M ﹤0.01% 1444
2025
Q1
$22.8M Buy
1,375,213
+142,847
+12% +$2.6M ﹤0.01% 1554
2024
Q4
$22.6M Buy
1,232,366
+106,236
+9% +$1.71M ﹤0.01% 1615
2024
Q3
$17.3M Sell
1,126,130
-18,628
-2% -$311K ﹤0.01% 1706
2024
Q2
$18.6M Sell
1,144,758
-47,068
-4% -$760K ﹤0.01% 1597
2024
Q1
$22M Sell
1,191,826
-22,307
-2% -$553K ﹤0.01% 1526
2023
Q4
$38M Sell
1,214,133
-6,544
-0.5% -$156K 0.01% 1199
2023
Q3
$25.4M Buy
1,220,677
+57,555
+5% +$1.56M ﹤0.01% 1391
2023
Q2
$27.9M Sell
1,163,122
-3,602
-0.3% -$80.1K 0.01% 1372
2023
Q1
$22M Buy
1,166,724
+39,440
+3% +$751K ﹤0.01% 1499
2022
Q4
$17.9M Buy
1,127,284
+10,345
+0.9% +$162K ﹤0.01% 1608
2022
Q3
$18.3M Sell
1,116,939
-13,848
-1% -$224K ﹤0.01% 1547
2022
Q2
$15.9M Sell
1,130,787
-39,779
-3% -$742K ﹤0.01% 1696
2022
Q1
$28.4M Sell
1,170,566
-54,096
-4% -$1.31M 0.01% 1427
2021
Q4
$28.6M Sell
1,224,662
-74,657
-6% -$1.5M ﹤0.01% 1518
2021
Q3
$21.6M Sell
1,299,319
-40,331
-3% -$777K ﹤0.01% 1755
2021
Q2
$32.7M Buy
1,339,650
+733,652
+121% +$16.6M 0.01% 1525
2021
Q1
$15.6M Buy
605,998
+8,625
+1% +$380K ﹤0.01% 2001
2020
Q4
$31.9M Buy
597,373
+9,490
+2% +$471K 0.01% 1440
2020
Q3
$24.3M Sell
587,883
-16,917
-3% -$731K 0.01% 1481
2020
Q2
$29.3M Sell
604,800
-892,709
-60% -$42.9M 0.01% 1314
2020
Q1
$63.3M Buy
1,497,509
+21,989
+1% +$906K 0.02% 653
2019
Q4
$63.1M Buy
1,475,520
+54,925
+4% +$2.39M 0.01% 846
2019
Q3
$51.1M Sell
1,420,595
-48,189
-3% -$1.46M 0.01% 957
2019
Q2
$39.3M Sell
1,468,784
-17,862
-1% -$456K 0.01% 1188
2019
Q1
$39.9M Buy
1,486,646
+143,297
+11% +$3.35M 0.01% 1148
2018
Q4
$21.7M Buy
1,343,349
+56,449
+4% +$1.1M 0.01% 1514
2018
Q3
$26.7M Buy
1,286,900
+25,365
+2% +$399K 0.01% 1543
2018
Q2
$19.3M Buy
1,261,535
+771,631
+158% +$13.8M ﹤0.01% 1807
2018
Q1
$11M Buy
489,904
+17,680
+4% +$489K ﹤0.01% 2108
2017
Q4
$14.2M Buy
472,224
+691
+0.1% +$22.1K ﹤0.01% 1957
2017
Q3
$17.8M Buy
471,533
+2,090
+0.4% +$68K ﹤0.01% 1791
2017
Q2
$13.1M Sell
469,443
-4,885
-1% -$146K ﹤0.01% 1988
2017
Q1
$16.3M Buy
474,328
+11,862
+3% +$419K ﹤0.01% 1779
2016
Q4
$13.3M Buy
462,466
+26,318
+6% +$696K ﹤0.01% 1896
2016
Q3
$13.9M Buy
436,148
+27,821
+7% +$943K ﹤0.01% 1848
2016
Q2
$13.3M Sell
408,327
-576,878
-59% -$19.3M ﹤0.01% 1827
2016
Q1
$27.7M Buy
985,205
+68,501
+7% +$1.49M 0.01% 1227
2015
Q4
$32.7M Buy
916,704
+17,599
+2% +$620K 0.01% 1104
2015
Q3
$29.7M Buy
899,105
+15,453
+2% +$643K 0.01% 1190
2015
Q2
$37M Sell
883,652
-12,158
-1% -$471K 0.01% 1090
2015
Q1
$29.2M Buy
895,810
+14,225
+2% +$489K 0.01% 1285
2014
Q4
$28M Sell
881,585
-24,565
-3% -$697K 0.01% 1282
2014
Q3
$22.4M Sell
906,150
-29,343
-3% -$686K 0.01% 1416
2014
Q2
$21.1M Sell
935,493
-26,063
-3% -$544K 0.01% 1472
2014
Q1
$23.4M Sell
961,556
-36,174
-4% -$915K 0.01% 1452
2013
Q4
$24.9M Sell
997,730
-45,949
-4% -$1.08M 0.01% 1342
2013
Q3
$28.7M Buy
1,043,679
+569,512
+120% +$11.9M 0.01% 1147
2013
Q2
$8.61M Buy
+474,167
New +$6.53M ﹤0.01% 2029

Other funds holding ACAD